VACCINOGEN INC 소개
Vaccinogen Inc. is a US biotechnology company based in Baltimore. It is currently developing a potential cancer immunotherapy called OncoVAX, where a patient's own tumor cells are used as the vaccine, adjuvanted by BCG. This product was evaluated in Phase III in colon cancer in the 1990s and another Phase III study, called ACTIVE, is currently recruiting stage II colon cancer patients. Vaccinogen calls its approach 'Active Specific Immunotherapy' or ASI.
Source: Wikipedia
산업Biotechnology
본사Frederick, MD
설립2007
법적 형태C Corporation
상태운영 중
주요 수치
법적 정보
| 법인명 | VACCINOGEN INC |
|---|---|
| 법적 형태 | C Corporation |
| SEC CIK | 1453001SEC EDGAR에서 보기 ↗ |
| 등기 주소 | Frederick, MD |
| 상태 | 운영 중 |
출처: SEC EDGAR · 2026년 11월 14일 업데이트